Contract between two companies delayed earlier peanut-allergy treatment

A protracted legal battle between Tanox, Genentech and Novartis illustrates the difficulties sometimes faced by companies that enter into drug development partnerships. When a trial for a potential peanut-allergy drug was halted amid accusations it infringed on the agreement between the three companies, patients taking part in the trial were taken off the drug, though it was showing promise in treating allergies.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations